HDC’s production consists of a wide range of dental implants manufactured from commercially pure titanium that satisfies the needs and preferences of surgeons.

The implants are of the self-tapping variety and BLE (Bone Lock Etching)surface treated. The surgical procedure is simplified by the self-tapping property and the carefully researched cutting angle ensures maximum efficiency, thus eliminating the need for tapping in most cases in line with well-known protocols.

Great attention is given to cleaning and decontamination processes. After the first cleaning process using appropriate solvents for the removal of major contaminants, the implants are passed through a specific surface decontamination cycle using Argon plasma cleaning. All cleaning, decontamination and packaging is carried out in a clean enviromment. The implant is supplied in a special double container which enables the transfer of the implant to the surgical site without handling and therefore minimises any risk of compromising its sterility. Sterilization is performed by Gamma radiation.

HDC’s Research and Development Department is always at the disposal of the client to help meet their requirements. This catalogue illustrates the actual production process which is constantly evolving. HDC is continually striving to create new solutions that will make it easier for the clinician and improve clinical successes as well as protecting patients health and comfort.

Surface Treatment

Bonelock Etching

Well-known clinicians together with an important certified Centre for Materials Treatment have worked in collaboration to study the micro-mechanical, biological and biochemistry aspect of the surface treatment capable of altering the morphology.

It has been widely demonstrated that the more the surface roughness is close to the fibroblast dimension the more capable it is of influencing cellular behaviour causing platelet activity, compared to a machined surface. This surface roughness ensures optimum bone-to-implant contact from the point of view of either the distribution and the dimension of the peak/depression relation and therefore helps clot stabilization and fibroblast adhesion during the primary healing phase.

The treatment increases bone-to-implant contact making a typical structure rough in cellular-scale. The acquired morphology acts like a sponge to fluids in the implant site. Increasing the bone-implant interface, together with the documented bony growth in relation to surface roughness, enables a reduced osteointegration period to 6/8 weeks and allows early loading and consequently a reduction in treatment time. SEM micrographs at 7.500 and 10.000 magnification revealed micro concavity of 5 microns medium size which is the optimum value for a perfect and early osteointegration.